Skip to main content
Joseph Ruggiero, MD, Oncology, New York, NY, New York-Presbyterian Hospital

JosephTRuggieroMD

Oncology New York, NY

Hematologic Oncology, Neuro-Oncology

Associate Professor, Medicine, Weill Cornell Medical College

Dr. Ruggiero is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ruggiero's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1983 - 1984
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1980 - 1983
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1977 - 1980
  • New York University School of Medicine
    New York University School of MedicineClass of 1977

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1978 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • Top Doctors: New York Metro Area Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2008-2013
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Harm Reduction: An Alternative Approach to Managing Addiction
    Harm Reduction: An Alternative Approach to Managing AddictionDecember 9th, 2020
  • Gastrointestinal Stromal Tumors Already Proving to Be Treatable with Targeted Therapies
    Gastrointestinal Stromal Tumors Already Proving to Be Treatable with Targeted TherapiesMarch 23rd, 2016

Hospital Affiliations